Reply on the Risk of Ovarian Malignancy Algorithm
Author Information
Author(s): Van Gorp T, Timmerman D, Vergote I
Primary Institution: Universitair Ziekenhuis Leuven, Katholieke Universiteit Leuven
Conclusion
The study found that neither HE4 nor the combination of HE4 and CA125 improves the diagnosis of ovarian cancer in patients with an adnexal mass.
Supporting Evidence
- The study had a sample size of 389 patients, which is larger than previous studies.
- The authors noted that the addition of HE4 to CA125 did not improve diagnostic accuracy.
- The study faced challenges with missing data and patient withdrawals.
Takeaway
The study looked at a test for ovarian cancer and found it didn't work better than existing tests, which is disappointing.
Methodology
The study involved a prospective analysis of patients with pelvic masses who planned to undergo surgery.
Potential Biases
There was a potential selection bias due to the patient population being from a tertiary center.
Limitations
The study had issues with missing pathology reports and patient withdrawals.
Participant Demographics
The study included patients with pelvic masses, with a notable proportion of postmenopausal patients and various tumor types.
Statistical Information
P-Value
0.17
Statistical Significance
p=0.17
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website